Track 10 : Pharmacogenomics & Pharmacoproteomics

Pharmacogenomics is the study of the impact that order plays in medication response. Its name is a reflection of the blending of genetics and medicine. Pharmacogenomics examines how a person's genetic make-up influences how they respond to drugs.

Pharmacoproteomics is a rapidly developing discipline where genetics approaches are used to create pharmacological drugs. Personalized medicine is important in this area of research. Genetics is the full complement of proteins that an organism or tissue expresses at a given moment and under certain conditions. The whole collection of proteins used in the study will serve as a substitute for significantly more sophisticated pharmacodynamics assays at a lower cost in terms of time, financial output, and clinical risk.

  • Enzymatic metabolizers of drugs
  • Implementation of clinical prediction
  • Polypharmacy

 


 


    Related Conference of Track 10 : Pharmacogenomics & Pharmacoproteomics

    September 15-16, 2025

    29th Global Congress on Biotechnology

    Paris, France
    December 04-05, 2025

    9th International Conference on Protein Engineering

    Paris, France
    December 11-12, 2025

    7th International Conference on Biochemistry

    Prague, Czech Republic
    December 22-23, 2025

    29th World Congress on Biotechnology

    Barcelona, Spain
    April 27-28, 2026

    7th Annual Congress on Biosimilars and Future Biotherapeutics

    Paris, Aland Islands
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE

    Track 10 : Pharmacogenomics & Pharmacoproteomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in